Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Translational Development Acquisition (TDAC) Change in Cash (2024 - 2026)

Translational Development Acquisition's Change in Cash history spans 3 years, with the latest figure at -$5157.0 for Q1 2026.

  • On a quarterly basis, Change in Cash rose 97.77% to -$5157.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$181970.0, a N/A change, with the full-year FY2025 number at -$408387.0, down 193.63% from a year prior.
  • Change in Cash came in at -$5157.0 for Q1 2026, up from -$17363.0 in the prior quarter.
  • The five-year high for Change in Cash was $214136.0 in Q4 2024, with the low at -$231574.0 in Q1 2025.
  • Historically, Change in Cash has averaged -$6770.1 across 3 years, with a median of -$5157.0 in 2026.
  • Biggest five-year swings in Change in Cash: crashed 108.11% in 2025 and later surged 97.77% in 2026.
  • Year by year, Change in Cash stood at $214136.0 in 2024, then tumbled by 108.11% to -$17363.0 in 2025, then soared by 70.3% to -$5157.0 in 2026.
  • Business Quant data shows Change in Cash for TDAC at -$5157.0 in Q1 2026, -$17363.0 in Q4 2025, and $11895.0 in Q3 2025.